Live feed08:30:00·1hPRReleasevia QuantisnowUltragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 MillionByQuantisnow·Wall Street's wire, on your screen.RARE· Ultragenyx Pharmaceutical Inc.Health Care
